Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Baricitinib successfully treated severe hair loss.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Tph cells are linked to the severity of systemic lupus erythematosus.